- Home
- ACIU vs BEEP Comparison
ACIU vs BEEP Comparison
Compare ACIU & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- BEEP
- Stock Information
- Founded
- ACIU 2003
- BEEP 2015
- Country
- ACIU Switzerland
- BEEP United States
- Employees
- ACIU N/A
- BEEP N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- BEEP Blank Checks
- Sector
- ACIU Health Care
- BEEP Finance
- Exchange
- ACIU Nasdaq
- BEEP Nasdaq
- Market Cap
- ACIU 189.1M
- BEEP 162.0M
- IPO Year
- ACIU 2016
- BEEP N/A
- Fundamental
- Price
- ACIU $2.07
- BEEP $4.60
- Analyst Decision
- ACIU Strong Buy
- BEEP Strong Buy
- Analyst Count
- ACIU 1
- BEEP 2
- Target Price
- ACIU $12.00
- BEEP $6.75
- AVG Volume (30 Days)
- ACIU 139.5K
- BEEP 116.2K
- Earning Date
- ACIU 08-05-2025
- BEEP 08-12-2025
- Dividend Yield
- ACIU N/A
- BEEP N/A
- EPS Growth
- ACIU N/A
- BEEP N/A
- EPS
- ACIU N/A
- BEEP N/A
- Revenue
- ACIU $32,014,254.00
- BEEP $36,416,000.00
- Revenue This Year
- ACIU N/A
- BEEP $5.22
- Revenue Next Year
- ACIU $533.21
- BEEP $5.13
- P/E Ratio
- ACIU N/A
- BEEP N/A
- Revenue Growth
- ACIU 91.20
- BEEP 13.81
- 52 Week Low
- ACIU $1.43
- BEEP $2.48
- 52 Week High
- ACIU $4.26
- BEEP $4.86
- Technical
- Relative Strength Index (RSI)
- ACIU 56.20
- BEEP 70.23
- Support Level
- ACIU $1.65
- BEEP $3.95
- Resistance Level
- ACIU $2.17
- BEEP $4.66
- Average True Range (ATR)
- ACIU 0.17
- BEEP 0.25
- MACD
- ACIU -0.01
- BEEP 0.06
- Stochastic Oscillator
- ACIU 70.37
- BEEP 91.21
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. It operates in a single reportable segment: parking. The company derives majority of revenue from Percentage rental income.